- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7056 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
Patent holdings for IPC class A61K 31/7056
Total number of patents in this class: 1254
10-year publication summary
|
112
|
95
|
102
|
94
|
138
|
97
|
91
|
74
|
68
|
48
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 2222 |
46 |
| Galecto Biotech AB | 72 |
33 |
| Boehringer Ingelheim Vetmedica GmbH | 1277 |
30 |
| Takeda Pharmaceutical Company Limited | 2712 |
29 |
| Kissei Pharmaceutical Co., Ltd. | 178 |
18 |
| Bausch Health Ireland Limited | 802 |
16 |
| President and Fellows of Harvard College | 6094 |
14 |
| Vertex Pharmaceuticals Incorporated | 1582 |
14 |
| Bristol-myers Squibb Company | 4742 |
13 |
| Boehringer Ingelheim International GmbH | 4493 |
13 |
| Centre National de La Recherche Scientifique | 11023 |
13 |
| GlycoMimetics, Inc. | 107 |
10 |
| Novartis AG | 10262 |
9 |
| Merck Sharp & Dohme Corp. | 2183 |
9 |
| Pfizer Inc. | 3386 |
8 |
| Cmpd Licensing, LLC | 83 |
8 |
| Enanta Pharmaceuticals, Inc. | 425 |
8 |
| Idenix Pharmaceuticals LLC | 59 |
8 |
| Curology, Inc. | 63 |
8 |
| Merck Sharp & Dohme LLC | 3734 |
8 |
| Other owners | 939 |